BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18684055)

  • 1. Cancer-cell fusion with migratory bone-marrow-derived cells as an explanation for metastasis: new therapeutic paradigms.
    Pawelek JM
    Future Oncol; 2008 Aug; 4(4):449-52. PubMed ID: 18684055
    [No Abstract]   [Full Text] [Related]  

  • 2. Altered N-glycosylation in macrophage x melanoma fusion hybrids.
    Pawelek JM; Chakraborty AK; Rachkovsky ML; Orlow SJ; Bolognia JL; Sodi SA
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1011-27. PubMed ID: 10644005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer. Fusion for moving.
    Clawson GA
    Science; 2013 Nov; 342(6159):699-700. PubMed ID: 24202164
    [No Abstract]   [Full Text] [Related]  

  • 4. The cancer cell--leukocyte fusion theory of metastasis.
    Pawelek JM; Chakraborty AK
    Adv Cancer Res; 2008; 101():397-444. PubMed ID: 19055949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta1,6-branched oligosaccharides regulate melanin content and motility in macrophage-melanoma fusion hybrids.
    Chakraborty AK; Pawelek J
    Melanoma Res; 2007 Feb; 17(1):9-16. PubMed ID: 17235237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of alpha and beta integrin subunits in metastatic macrophage-melanoma fusion hybrids.
    Chakraborty AK; Funasaka Y; Ichihashi M; Pawelek JM
    Melanoma Res; 2009 Dec; 19(6):343-9. PubMed ID: 22760065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis.
    Pawelek JM; Chakraborty AK
    Nat Rev Cancer; 2008 May; 8(5):377-86. PubMed ID: 18385683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion hybrids with macrophage and melanoma cells up-regulate N-acetylglucosaminyltransferase V, beta1-6 branching, and metastasis.
    Chakraborty AK; Pawelek J; Ikeda Y; Miyoshi E; Kolesnikova N; Funasaka Y; Ichihashi M; Taniguchi N
    Cell Growth Differ; 2001 Dec; 12(12):623-30. PubMed ID: 11751457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-localization of beta1,6-branched oligosaccharides and coarse melanin in macrophage-melanoma fusion hybrids and human melanoma cells in vitro.
    Rupani R; Handerson T; Pawelek J
    Pigment Cell Res; 2004 Jun; 17(3):281-8. PubMed ID: 15140074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion of bone marrow-derived cells with cancer cells: metastasis as a secondary disease in cancer.
    Pawelek JM
    Chin J Cancer; 2014 Mar; 33(3):133-9. PubMed ID: 24589183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth characteristics of clonal cell populations constituting a B16 melanoma metastasis model system.
    Stackpole CW; Alterman AL; Fornabaio DM
    Invasion Metastasis; 1985; 5(3):125-43. PubMed ID: 3888909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusion in cancer: an explanatory model for aneuploidy, metastasis formation, and drug resistance.
    Mohr M; Zaenker KS; Dittmar T
    Methods Mol Biol; 2015; 1313():21-40. PubMed ID: 25947654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GnT-V expression and metastatic phenotypes in macrophage-melanoma fusion hybrids is down-regulated by 5-Aza-dC: evidence for methylation sensitive, extragenic regulation of GnT-V transcription.
    Chakraborty AK; Sousa Jde F; Chakraborty D; Funasaka Y; Bhattacharya M; Chatterjee A; Pawelek J
    Gene; 2006 Jun; 374():166-73. PubMed ID: 16556489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of solid tumor stem cells in melanoma: Part 2.
    Margolin KA
    Curr Oncol Rep; 2008 Sep; 10(5):430. PubMed ID: 18706271
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumour-cell fusion as a source of myeloid traits in cancer.
    Pawelek JM
    Lancet Oncol; 2005 Dec; 6(12):988-93. PubMed ID: 16321767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cells: Invitation to a second round.
    Dirks P
    Nature; 2010 Jul; 466(7302):40-1. PubMed ID: 20596007
    [No Abstract]   [Full Text] [Related]  

  • 17. Human prostate cancer in a clinically relevant xenograft mouse model: identification of β(1,6)-branched oligosaccharides as a marker of tumor progression.
    Lange T; Ullrich S; Müller I; Nentwich MF; Stübke K; Feldhaus S; Knies C; Hellwinkel OJ; Vessella RL; Abramjuk C; Anders M; Schröder-Schwarz J; Schlomm T; Huland H; Sauter G; Schumacher U
    Clin Cancer Res; 2012 Mar; 18(5):1364-73. PubMed ID: 22261809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell fusion theory: can it explain what triggers metastasis?
    Carter A
    J Natl Cancer Inst; 2008 Sep; 100(18):1279-81. PubMed ID: 18780857
    [No Abstract]   [Full Text] [Related]  

  • 19. Progression markers in metastasizing human melanoma cells xenografted to nude mice (review).
    van Muijen GN; Cornelissen IM; Jansen CF; Ruiter DJ
    Anticancer Res; 1989; 9(4):879-84. PubMed ID: 2683999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cancer stem cell].
    Sakashita H; Ieta K; Haraguchi N; Inoue Y; Yoshizawa Y; Mori M
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1721-9. PubMed ID: 18030004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.